Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion type Assertion NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_head.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion description "[Therefore, re-establishing of RBP2-H1 could evolve as an interesting novel approach in developing experimental treatments for metastatic melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_provenance.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion evidence source_evidence_literature NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_provenance.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion SIO_000772 16645588 NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_provenance.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion wasDerivedFrom befree-20140225 NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_provenance.
- NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_assertion wasGeneratedBy ECO_0000203 NP796417.RAKnxW7mpnv7bPs6XUtW8dP1xVeNtocBgM4MFRktGqadM130_provenance.